EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PROM2 overexpression induces metastatic potential through epithelial‐to‐mesenchymal transition and ferroptosis resistance in human cancers

Justine Paris iD, Claire Wilhelm, Celeste Lebbé, Mohammed Elmallah, Frédéric Pamoukdjian, Audrey Héraud, Guillaume Gapihan, Aurore Van De Walle iD, Van Nhan Tran, Diaddin Hamdan, Clara Allayous, Maxime Battistella und 7 weitere

Clinical and Translational Medicine · 2024-03 · 14 (3)

DOI: 10.1002/ctm2.1632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 21.03.2024. Verfasst von Justine Paris und 18 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, INSERM, UMR_S942 MASCOT, Paris, France. Hauptthemen laut MEDLINE: Melanoma, Ferroptosis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Despite considerable therapeutic advances in the last 20 years, metastatic cancers remain a major cause of death. We previously identified prominin‐2 (PROM2) as a biomarker predictive of distant metastases and decreased survival, thus providing a promising bio‐target. In this translational study, we set out to decipher the biological roles of PROM2 during the metastatic process and resistance to cell death, in particular for metastatic melanoma. Methods and results Methods and results: We demonstrated that PROM2 overexpression was closely linked to an increased metastatic potential through the increase of epithelial‐to‐mesenchymal transition (EMT) marker expression and ferroptosis resistance. This was also found in renal cell carcinoma and triple negative breast cancer patient‐derived xenograft models. Using an oligonucleotide anti‐sense anti‐PROM2, we efficaciously decreased PROM2 expression and prevented metastases in melanoma xenografts. We also demonstrated that PROM2 was implicated in an aggravation loop, contributing to increase the metastatic burden both in murine metastatic models and in patients with metastatic melanoma. The metastatic burden is closely linked to PROM2 expression through the expression of EMT markers and ferroptosis cell death resistance in a deterioration loop.

Conclusion

Our results open the way for further studies using PROM2 as a bio‐target in resort situations in human metastatic melanoma and also in other cancer types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaFerroptosisHumansAnimalsMiceCell Line, TumorEpithelial-Mesenchymal TransitionMembrane Glycoproteins

Stichwörter der Autor:innen

breast cancerepithelial‐to‐mesenchymal transitionferroptosis resistancemelanomametastasesprominin‐2renal cancer

Substanzen

PROM2 protein, humanMembrane Glycoproteins

Autor:innen und Institutionen

  • Université Paris Cité, INSERM, UMR_S942 MASCOT, Paris, France.
  • Laboratoire Physico Chimie Curie, Institut Curie, CNRS, PSL Research University, Paris, France.
  • Université Paris Cité, INSERM, Paris, France.
  • APHP, Dermatolo-Oncology, Hôpital Saint Louis, Paris, France.
  • Inserm U1327 ISCHEMIA, Université de Tours, Faculté de Médecine, Tours, France.
  • APHP, Hôpital Avicenne, Médecine Gériatrique, Bobigny, France.

ORCID-Profile: Justine Paris, Aurore Van De Walle, Guilhem Bousquet

Zitieren

APA

Paris, J., Wilhelm, C., Lebbé, C., Elmallah, M., Pamoukdjian, F., Héraud, A., Gapihan, G., Walle, A. V., Tran, V. N., Hamdan, D., Allayous, C., Battistella, M., Van Glabeke, E., Lim, K. W., Leboeuf, C., Roger, S., Falgarone, G., Phan, A. T., & Bousquet, G. (2024). PROM2 overexpression induces metastatic potential through epithelial‐to‐mesenchymal transition and ferroptosis resistance in human cancers. Clinical and Translational Medicine, 14(3). https://doi.org/10.1002/ctm2.1632

Vancouver

Paris J, Wilhelm C, Lebbé C, Elmallah M, Pamoukdjian F, Héraud A, et al. PROM2 overexpression induces metastatic potential through epithelial‐to‐mesenchymal transition and ferroptosis resistance in human cancers. Clinical and Translational Medicine. 2024;14(3). doi:10.1002/ctm2.1632

BibTeX
@article{Paris2024,
  author = {Paris, Justine and Wilhelm, Claire and Lebbé, Celeste and Elmallah, Mohammed and Pamoukdjian, Frédéric and Héraud, Audrey and Gapihan, Guillaume and Walle, Aurore Van De and Tran, Van Nhan and Hamdan, Diaddin and Allayous, Clara and Battistella, Maxime and Van Glabeke, Emmanuel and Lim, Kah Wai and Leboeuf, Christophe and Roger, Sébastien and Falgarone, Géraldine and Phan, Anh Tuan and Bousquet, Guilhem},
  title = {PROM2 overexpression induces metastatic potential through epithelial‐to‐mesenchymal transition and ferroptosis resistance in human cancers},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  volume = {14},
  number = {3},
  doi = {10.1002/ctm2.1632}
}
Kostenlos starten →